Connection

JASVINDER SINGH to Quality of Life

This is a "connection" page, showing publications JASVINDER SINGH has written about Quality of Life.
Connection Strength

4.722
  1. Recent health-related quality of life, but not change, predicted mortality and healthcare utilization. J Clin Epidemiol. 2021 12; 140:13-21.
    View in: PubMed
    Score: 0.375
  2. Patient Perceptions of Gout Management Goals: A Cross-sectional Internet Survey. J Clin Rheumatol. 2020 Jun; 26(4):129-133.
    View in: PubMed
    Score: 0.344
  3. Patient Burden of Axial Spondyloarthritis. J Clin Rheumatol. 2017 Oct; 23(7):383-391.
    View in: PubMed
    Score: 0.286
  4. Racial differences in health-related quality of life and functional ability in patients with gout. Rheumatology (Oxford). 2017 01; 56(1):103-112.
    View in: PubMed
    Score: 0.268
  5. Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales. Health Qual Life Outcomes. 2014 Dec 18; 12:187.
    View in: PubMed
    Score: 0.236
  6. Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity. Drugs. 2010; 70(2):121-45.
    View in: PubMed
    Score: 0.167
  7. Effect of comorbidity on quality of life of male veterans with prevalent primary total knee arthroplasty. Clin Rheumatol. 2009 Sep; 28(9):1083-9.
    View in: PubMed
    Score: 0.160
  8. Spondyloarthritis is associated with poor function and physical health-related quality of life. J Rheumatol. 2009 May; 36(5):1012-20.
    View in: PubMed
    Score: 0.159
  9. Quality of life and quality of care for patients with gout. Curr Rheumatol Rep. 2009 Apr; 11(2):154-60.
    View in: PubMed
    Score: 0.159
  10. Health-related quality of life in veterans with prevalent total knee arthroplasty and total hip arthroplasty. Rheumatology (Oxford). 2008 Dec; 47(12):1826-31.
    View in: PubMed
    Score: 0.154
  11. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008 Sep; 67(9):1310-6.
    View in: PubMed
    Score: 0.146
  12. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care. 2007 Dec; 13 Suppl 9:S237-51.
    View in: PubMed
    Score: 0.145
  13. Effect of health-related quality of life on women and men's Veterans Affairs (VA) health care utilization and mortality. J Gen Intern Med. 2007 Sep; 22(9):1260-7.
    View in: PubMed
    Score: 0.141
  14. Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: the veterans arthritis quality of life study. Semin Arthritis Rheum. 2005 Apr; 34(5):755-65.
    View in: PubMed
    Score: 0.120
  15. Health-related quality of life, functional impairment, and healthcare utilization by veterans: veterans' quality of life study. J Am Geriatr Soc. 2005 Jan; 53(1):108-13.
    View in: PubMed
    Score: 0.118
  16. Health-related quality of life profiles of adults with arthritis and/or fibromyalgia: a cross-sectional study. Qual Life Res. 2025 Feb; 34(2):523-534.
    View in: PubMed
    Score: 0.117
  17. SToRytelling to Improve Disease outcomes in Gout (STRIDE-GO): a multicenter, randomized controlled trial in African American veterans with gout. BMC Med. 2021 11 09; 19(1):265.
    View in: PubMed
    Score: 0.095
  18. Time-trends in cocaine, hallucinogen, amphetamine, and sedative/anxiolytic/hypnotic use disorder hospitalizations in rheumatic diseases: a national time-trends study. Clin Rheumatol. 2021 Jul; 40(7):3007-3014.
    View in: PubMed
    Score: 0.091
  19. Belimumab for systemic lupus erythematosus. Cochrane Database Syst Rev. 2021 02 25; 2:CD010668.
    View in: PubMed
    Score: 0.091
  20. Validation of the Hip Disability and Osteoarthritis Outcome Score and Knee Injury and Osteoarthritis Outcome Score Pain and Function Subscales for Use in Total Hip Replacement and Total Knee Replacement Clinical Trials. J Arthroplasty. 2020 05; 35(5):1200-1207.e4.
    View in: PubMed
    Score: 0.084
  21. Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review. J Rheumatol. 2020 10 01; 47(10):1565-1574.
    View in: PubMed
    Score: 0.083
  22. When Has a Knee or Hip Replacement Failed? A Patient Perspective. J Rheumatol. 2021 03; 48(3):447-453.
    View in: PubMed
    Score: 0.083
  23. Tai Chi for rheumatoid arthritis. Cochrane Database Syst Rev. 2019 09 25; 9:CD004849.
    View in: PubMed
    Score: 0.082
  24. Increasing comorbidity is associated with worsening physical function and pain after primary total knee arthroplasty. BMC Musculoskelet Disord. 2016 10 07; 17(1):421.
    View in: PubMed
    Score: 0.067
  25. Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making. Arthritis Res Ther. 2015 Dec 17; 17:367.
    View in: PubMed
    Score: 0.063
  26. Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update. Qual Life Res. 2014 Sep; 23(7):1997-2013.
    View in: PubMed
    Score: 0.056
  27. Patients with osteoarthritis and avascular necrosis have better functional outcomes and those with avascular necrosis worse pain outcomes compared to rheumatoid arthritis after primary hip arthroplasty: a cohort study. BMC Med. 2013 Sep 24; 11:210.
    View in: PubMed
    Score: 0.054
  28. Cerebrovascular disease is associated with outcomes after total knee arthroplasty: a US total joint registry study. J Arthroplasty. 2014 Jan; 29(1):40-3.
    View in: PubMed
    Score: 0.053
  29. The relation between cancer patient treatment decision-making roles and quality of life. Cancer. 2013 Jun 15; 119(12):2342-9.
    View in: PubMed
    Score: 0.052
  30. Emerging therapies for gout. Expert Opin Emerg Drugs. 2012 Dec; 17(4):511-8.
    View in: PubMed
    Score: 0.051
  31. Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials. J Rheumatol. 2012 Jul; 39(7):1450-7.
    View in: PubMed
    Score: 0.049
  32. Responsiveness differences in outcome instruments after revision hip arthroplasty: what are the implications? BMC Musculoskelet Disord. 2011 May 23; 12:107.
    View in: PubMed
    Score: 0.046
  33. Minimally important differences of the gout impact scale in a randomized controlled trial. Rheumatology (Oxford). 2011 Jul; 50(7):1331-6.
    View in: PubMed
    Score: 0.045
  34. Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions. J Am Acad Orthop Surg. 2010 Feb; 18(2):72-82.
    View in: PubMed
    Score: 0.042
  35. The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet. 2009 Jun; 12(3):301-11.
    View in: PubMed
    Score: 0.040
  36. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009 May; 48(5):582-6.
    View in: PubMed
    Score: 0.040
  37. Evaluation of an instrument assessing influence of Gout on health-related quality of life. J Rheumatol. 2008 Dec; 35(12):2406-14.
    View in: PubMed
    Score: 0.038
  38. Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus. Semin Arthritis Rheum. 2025 Jun; 72:152669.
    View in: PubMed
    Score: 0.030
  39. Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus. Semin Arthritis Rheum. 2025 Jun; 72:152670.
    View in: PubMed
    Score: 0.030
  40. Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. J Allergy Clin Immunol. 2023 12; 152(6):1470-1492.
    View in: PubMed
    Score: 0.027
  41. Telemedicine in rheumatology care: A systematic review. Semin Arthritis Rheum. 2022 10; 56:152045.
    View in: PubMed
    Score: 0.025
  42. Perioperative assessment of muscle inflammation susceptibility in patients with end-stage osteoarthritis. J Appl Physiol (1985). 2022 04 01; 132(4):984-994.
    View in: PubMed
    Score: 0.024
  43. Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy. Cochrane Database Syst Rev. 2020 04 21; 4:CD012879.
    View in: PubMed
    Score: 0.021
  44. Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018. J Rheumatol. 2019 10; 46(10):1355-1359.
    View in: PubMed
    Score: 0.020
  45. Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients. Osteoarthritis Cartilage. 2018 10; 26(10):1311-1318.
    View in: PubMed
    Score: 0.019
  46. Developing a core outcome domain set to assessing effectiveness of interdisciplinary multimodal pain therapy: the VAPAIN consensus statement on core outcome domains. Pain. 2018 04; 159(4):673-683.
    View in: PubMed
    Score: 0.019
  47. Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment. Health Qual Life Outcomes. 2017 Sep 21; 15(1):183.
    View in: PubMed
    Score: 0.018
  48. Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets. J Rheumatol. 2017 Oct; 44(10):1551-1559.
    View in: PubMed
    Score: 0.018
  49. Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial. Clin Rheumatol. 2017 Jun; 36(6):1357-1367.
    View in: PubMed
    Score: 0.017
  50. Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations. Pain. 2016 Sep; 157(9):1836-1850.
    View in: PubMed
    Score: 0.017
  51. Remembering the forgotten non-communicable diseases. BMC Med. 2014 Oct 22; 12:200.
    View in: PubMed
    Score: 0.015
  52. Outcome domains for studies of acute and chronic gout. J Rheumatol. 2009 Oct; 36(10):2342-5.
    View in: PubMed
    Score: 0.010
  53. Progress in measurement instruments for acute and chronic gout studies. J Rheumatol. 2009 Oct; 36(10):2346-55.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.